Staff Reporter (Health Care, Law)
Los Angeles and Ventura counties are slated for the less restrictive orange tier on Monday and Wednesday, respectively, but county officials are reserving the right to implement their own limits for sectors of the economy.
Second Sight Medical Products Inc. on Thursday announced its board of directors has named Scott Dunbar as its new acting chief executive, replacing Matthew Pfeffer.
Encino law firm Alpert Barr & Grant on Wednesday announced a plan to merge with Shenon Law on April 1, taking on three lawyers and two paralegals from the Sherman Oaks firm.
Amgen Inc. on Tuesday announced plans to acquire Rodeo Therapeutics Corp., a private biopharmaceutical company based in Seattle.
Second Sight Medical Products on Monday closed its $27.9 million private stock placement, selling 4.7 million shares at $6 each, a move first announced last Wednesday.
Document service and Accion co-market to small businesses.
LegalZoom decided to partner with Bay Area nonprofit Accion Opportunity Fund at the beginning of March to increase legal services and capital for clients across both organizations.
Real estate attorney Fred Gaines sees development up.
Real estate law firm Gaines & Stacey has seen a flurry of business thanks to a booming housing market and pandemic-related lease negotiations, founder Fred Gaines said.
Shortened name, fresh logo update century-old firm
Law firm Lewis Roca Rothgerber Christie has completed a rebrand initiative which includes a new visual identity, website and shortened name – Lewis Roca.
Nicholas Lymberopoulos takes job with $644 million building project.
Providence Cedars-Sinai Tarzana Medical Center has chosen one of its own executives – Nicholas Lymberopoulos – to be its new chief executive following an eight-month-long national search, the hospital has announced.
Three years ago, Michael Castagna moved MannKind to Westlake Village from Valencia to help the company hire and retain top talent.
Michael Castagna is chief executive of biopharmaceutical company MannKind Corp. in Westlake Village. Prior to working at MannKind, Castagna served in various executive roles at Amgen Inc. in nearby Thousand Oaks, and its New York rival Bristol-Myers Squibb. MannKind, founded by late billionaire entrepreneur Al Mann, moved to the Conejo Valley from Valencia in 2017. Currently, MannKind is focused on developing drug treatments for rare lung and endocrine diseases while continuing to market its flagship drug Afrezza, an inhalable insulin treatment for diabetes. MannKind currently has 250 employees and expects to add 100 employees by this time next year, Castagna said.